Results 181 to 190 of about 256,729 (300)
Myo-Guide: A Machine Learning-Based Web Application for Neuromuscular Disease Diagnosis With MRI. [PDF]
Verdu-Diaz J +58 more
europepmc +1 more source
Muscle biopsy practices in the evaluation of neuromuscular disease: A systematic literature review. [PDF]
Ross L +5 more
europepmc +1 more source
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga +20 more
wiley +1 more source
Cardiopulmonary Recovery After Maximal Exercise in Individuals with Neuromuscular Disease and Limited Mobility. [PDF]
Blumberg Y +13 more
europepmc +1 more source
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar +6 more
wiley +1 more source
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy. [PDF]
Mitha A +4 more
europepmc +1 more source
ABSTRACT Neurological disorders represent a critical domain within global health, necessitating advanced interventions to address complex pathologies such as tumors, functional disorders, and cerebrovascular diseases. Despite the proven benefits of early intervention, current treatment paradigms face significant challenges: (1) limited precision in ...
Qing Ye +14 more
wiley +1 more source
Therapeutic targeting of RNA for neurological and neuromuscular disease. [PDF]
Bubenik JL, Scotti MM, Swanson MS.
europepmc +1 more source
A case for genomic medicine in South African paediatric patients with neuromuscular disease. [PDF]
Raga SV +6 more
europepmc +1 more source

